How Long Cannabis Stays in Your Blood Depends on How You Consume It
Smoking and vaporizing cannabis produced nearly identical blood cannabinoid levels, while edibles produced very different metabolite patterns, and researchers identified potential markers for recent use.
Quick Facts
What This Study Found
Researchers gave the same dose of cannabis to both frequent and occasional users through three routes: smoking, vaporizing, and eating. They then tracked THC and its metabolites in blood for up to 72 hours.
Smoking and vaporizing produced remarkably similar blood cannabinoid patterns. Edibles, however, produced significantly higher levels of the metabolites THCCOOH and THCCOOH-glucuronide.
Two minor cannabinoids, cannabigerol (CBG) and cannabinol (CBN), appeared in blood only after inhaling cannabis and disappeared quickly, making them potential markers of recent use. They were not detected at all after oral consumption.
A combined cutoff of THC at or above 5 micrograms per liter plus a specific metabolite ratio produced detection windows under 8 hours for all consumption routes in frequent users.
Key Numbers
CBG and CBN were detected after inhalation with short detection windows but not after oral dosing. A combined THC greater than or equal to 5 micrograms per liter plus THCCOOH/11-OH-THC ratio less than 20 produced detection windows under 8 hours for all routes in frequent smokers. No occasional smoker tested positive 1.5 hours after inhalation or 12 hours after oral use with this cutoff.
How They Did This
This was a controlled, within-subject clinical trial. Participants received 50.6 mg of THC via smoking, vaporizing, or oral brownie across separate sessions. Blood was collected at multiple time points over 54 hours (occasional users) or 72 hours (frequent users). Researchers measured THC, its phase I and phase II metabolites, and minor cannabinoids using validated analytical methods.
Why This Research Matters
Distinguishing recent cannabis use from past use is critical for DUI enforcement and workplace testing. Standard THC blood tests can show positive results for up to 30 days in frequent users, even when they are no longer impaired. This study provides evidence for biomarkers and cutoff combinations that narrow the detection window to hours rather than days.
The Bigger Picture
As cannabis legalization expands, law enforcement and employers need better tools to identify recent use rather than past use. This study establishes that vaping and smoking deliver THC equivalently, that edibles create a distinct metabolic signature, and that combining multiple biomarkers can narrow detection to recent consumption.
What This Study Doesn't Tell Us
The study used a single THC dose (50.6 mg). Real-world consumption varies widely in dose and potency. The sample size was relatively small. The proposed cutoffs need validation in larger populations and real-world settings before adoption in legal or workplace contexts.
Questions This Raises
- ?Could CBG and CBN be used as roadside markers of recent cannabis inhalation?
- ?How do these pharmacokinetic profiles change with higher-potency products now common in legal markets?
- ?Would the proposed cutoffs work for people who use cannabis multiple times per day?
Trust & Context
- Key Stat:
- Detection windows under 8 hours using combined THC and metabolite ratio cutoffs across all consumption routes.
- Evidence Grade:
- Strong evidence from a controlled clinical trial with within-subject design comparing multiple administration routes using standardized doses.
- Study Age:
- Published in 2016. Cannabis products have become more potent since this study, which may affect detection windows.
- Original Title:
- Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
- Published In:
- Clinical chemistry, 62(12), 1579-1592 (2016)
- Authors:
- Newmeyer, Matthew N(3), Swortwood, Madeleine J(3), Barnes, Allan J(6), Abulseoud, Osama A, Scheidweiler, Karl B, Huestis, Marilyn A
- Database ID:
- RTHC-01233
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does vaping produce different blood THC levels than smoking?
No. This study found very few differences between smoked and vaporized cannabis blood pharmacokinetics. The two routes deliver THC to the blood in essentially the same way.
Can a blood test tell if someone used cannabis recently versus days ago?
Standard THC tests cannot reliably distinguish recent from past use. This study found that combining THC levels with metabolite ratios, plus checking for minor cannabinoids like CBG and CBN, could narrow the window to under 8 hours.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
- does-weed-expire-shelf-life-potency
- how-to-store-weed-fresh-temperature-light
- what-is-dabbing-what-does-it-do-body
- what-are-moon-rocks-why-strong
Cite This Study
https://rethinkthc.com/research/RTHC-01233APA
Newmeyer, Matthew N; Swortwood, Madeleine J; Barnes, Allan J; Abulseoud, Osama A; Scheidweiler, Karl B; Huestis, Marilyn A. (2016). Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.. Clinical chemistry, 62(12), 1579-1592.
MLA
Newmeyer, Matthew N, et al. "Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.." Clinical chemistry, 2016.
RethinkTHC
RethinkTHC Research Database. "Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinet..." RTHC-01233. Retrieved from https://rethinkthc.com/research/newmeyer-2016-free-and-glucuronide-whole
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.